Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:55 PM
Ignite Modification Date:
2025-12-24 @ 6:55 PM
NCT ID:
NCT06252857
Eligibility Criteria:
Inclusion Criteria:
* Patients ≥18 years old
* Diagnosis of low-risk BCC based on CDE with OCT confirmation or with histopathological verification in case OCT diagnosis is doubtful.
* Tumors meeting the criteria for low-risk BCC
* Patient is able to understand the instruction regarding the study participation and application of IMQ treatment
Exclusion Criteria:
* Tumor location in the H-zone of the face or hairy scalp, anogenital area
* Diagnosis of recurrent BCC or previous skin cancer within 2cm of the treatment area
* Strong suspicion/diagnosis of high-risk BCC subtype or other skin condition on OCT or punch biopsy
* Women who are pregnant or breastfeeding
* Previous allergy or intolerance to IMQ
* No concurrent use any other systemic chemopreventive or immunosuppressive medication during the treatment period, 30 days before start and 3 months after the end of treatment
* Limited understanding of the Dutch language and not being able to give informed consent
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06252857
Study Brief:
Protocol Section:
NCT06252857